Alzamend Neuro (ALZN) Institutional Ownership $1.65 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Alzamend Neuro (NASDAQ:ALZN)CurrentInstitutional OwnershipPercentage49.61%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$264.82KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$19.23M Get ALZN Insider Trade Alerts Want to know when executives and insiders are buying or selling Alzamend Neuro stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALZN Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth Alzamend Neuro Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024Virtu Financial LLC26,482$26K0.0%N/A0.385% 2/2/2024Truist Financial Corp154,327$137K0.0%-93.3%2.168% 5/11/2022RFG Advisory LLC250,000$308K0.0%N/A0.277% 5/9/2022Qube Research & Technologies Ltd78,465$97K0.0%N/A0.087% 4/22/2022Truist Financial Corp2,314,907$2.85M0.0%N/A2.569% 1/31/2022Commonwealth Equity Services LLC116,666$221K0.0%N/A0.131% 11/16/2021Schonfeld Strategic Advisors LLC31,600$97K0.0%N/A0.036% 11/16/2021Two Sigma Investments LP172,913$533K0.0%N/A0.199% 11/16/2021Warberg Asset Management LLC14,000$43K0.0%N/A0.016% 11/15/2021Sassicaia Capital Advisers LLC93,762$289K0.8%N/A0.108% 9/17/2021Virtu Financial LLC15,402$135K0.0%N/A0.018% 8/16/2021Cubist Systematic Strategies LLC23,672$207K0.0%N/A0.028% 8/13/2021Geode Capital Management LLC44,600$389K0.0%N/A0.052% 8/11/2021Susquehanna International Group LLP57,030$498K0.0%N/A0.067% (Data available from 1/1/2016 forward) ALZN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALZN shares? During the previous two years, the following institutional investors and hedge funds held shares of Alzamend Neuro shares: Truist Financial Corp ($137K), Virtu Financial LLC ($26K).Learn more on ALZN's institutional investors. What percentage of Alzamend Neuro stock is owned by institutional investors? 49.61% of Alzamend Neuro stock is owned by institutional investors. Learn more on ALZN's institutional investor holdings. Which institutional investors have been buying Alzamend Neuro stock? The following institutional investors have purchased Alzamend Neuro stock in the last 24 months: Virtu Financial LLC ($26.48K). How much institutional buying is happening at Alzamend Neuro? Institutional investors have bought a total of 26,482 shares in the last 24 months. This purchase volume represents approximately $264.82K in transactions. Which Alzamend Neuro major shareholders have been selling company stock? The following institutional investors have sold Alzamend Neuro stock in the last 24 months: Truist Financial Corp ($2.16M). How much institutional selling is happening at Alzamend Neuro? Institutional investors have sold a total of 2,160,580 shares in the last 24 months. This volume of shares sold represents approximately $19.23M in transactions. Related Companies Sensei Biotherapeutics Institutional Ownership Aspira Women's Health Institutional Ownership Affimed Institutional Ownership Quince Therapeutics Institutional Ownership Vor Biopharma Institutional Ownership Anebulo Pharmaceuticals Institutional Ownership Aadi Bioscience Institutional Ownership Equillium Institutional Ownership Protara Therapeutics Institutional Ownership LAVA Therapeutics Institutional Ownership This page (NASDAQ:ALZN) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
